JP2610889B2
(ja)
|
1987-09-03 |
1997-05-14 |
日本臓器製薬株式会社 |
新規架橋アデニン誘導体
|
AU698419B2
(en)
|
1996-07-03 |
1998-10-29 |
Dainippon Sumitomo Pharma Co., Ltd. |
A novel purine derivative
|
HUP9903965A3
(en)
|
1996-08-28 |
2002-02-28 |
Pfizer |
Substituted 6,5-hetero-bicyclic derivatives
|
AU733316B2
(en)
|
1996-10-04 |
2001-05-10 |
Kyorin Pharmaceutical Co. Ltd. |
Pyrazolopyridylpyridazinone derivatives and process for preparing the same
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
US6339089B2
(en)
|
1997-08-13 |
2002-01-15 |
Fujirebio Inc. |
Pyrimidine nucleus-containing compound and a medicament containing the same for a blood oxygen partial pressure amelioration, and a method for preparing the same
|
WO1999028321A1
(fr)
|
1997-11-28 |
1999-06-10 |
Sumitomo Pharmaceuticals Company, Limited |
Nouveaux composes heterocycliques
|
TW572758B
(en)
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
BR9908004A
(pt)
|
1998-02-17 |
2001-12-18 |
Tularik Inc |
Composto, composição e método para prevençãoou supressão de uma infecção viral
|
US6110929A
(en)
|
1998-07-28 |
2000-08-29 |
3M Innovative Properties Company |
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
|
JP4342007B2
(ja)
|
1998-08-10 |
2009-10-14 |
大日本住友製薬株式会社 |
キナゾリン誘導体
|
JP4315300B2
(ja)
|
1998-08-10 |
2009-08-19 |
大日本住友製薬株式会社 |
新規なキナゾリン誘導体
|
US6458798B1
(en)
|
1998-08-27 |
2002-10-01 |
Sumitomo Pharmaceuticals Company, Limited |
Bicyclic pyrimidine compounds and therapeutic use thereof
|
WO2000048606A1
(en)
*
|
1999-02-18 |
2000-08-24 |
Oxigene, Inc. |
Compositions and methods for use in targeting vascular destruction
|
US6583148B1
(en)
|
1999-04-08 |
2003-06-24 |
Krenitsky Pharmaceuticals, Inc. |
Neurotrophic substituted pyrimidines
|
US6503908B1
(en)
|
1999-10-11 |
2003-01-07 |
Pfizer Inc |
Pharmaceutically active compounds
|
WO2002088079A2
(en)
|
2001-05-01 |
2002-11-07 |
Bristol-Myers Squibb Company |
Dual inhibitors of pde 7 and pde 4
|
AU2002364211A1
(en)
|
2001-12-21 |
2003-07-15 |
Bayer Pharmaceuticals Corporation |
Thienopyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
|
TW200407143A
(en)
|
2002-05-21 |
2004-05-16 |
Bristol Myers Squibb Co |
Pyrrolotriazinone compounds and their use to treat diseases
|
US7091232B2
(en)
|
2002-05-21 |
2006-08-15 |
Allergan, Inc. |
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
|
JPWO2003104230A1
(ja)
|
2002-06-07 |
2005-10-06 |
協和醗酵工業株式会社 |
二環性ピリミジン誘導体
|
MXPA05003193A
(es)
|
2002-09-27 |
2005-06-08 |
Sumitomo Pharma |
Compuesto de adenina novedoso y uso del mismo.
|
US8455458B2
(en)
|
2002-10-16 |
2013-06-04 |
Arthrodynamic Technologies, Animal Health Division, Inc. |
Composition and method for treating connective tissue damage
|
JP2007524615A
(ja)
|
2003-06-20 |
2007-08-30 |
コーリー ファーマシューティカル ゲーエムベーハー |
低分子トール様レセプター(tlr)アンタゴニスト
|
ATE465742T1
(de)
|
2003-09-05 |
2010-05-15 |
Anadys Pharmaceuticals Inc |
Tlr7-liganden zur behandlung von hepatitis c
|
BRPI0509258A8
(pt)
|
2004-03-26 |
2019-01-22 |
Astrazeneca Ab |
composto de 8-oxoadenina 9-substituída
|
US20070225303A1
(en)
|
2004-03-26 |
2007-09-27 |
Haruhisa Ogita |
8-Oxoadenine Compound
|
WO2007084413A2
(en)
|
2004-07-14 |
2007-07-26 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis c
|
EP1797050B1
(en)
|
2004-08-10 |
2013-10-23 |
Janssen Pharmaceutica NV |
Hiv inhibiting 1.2.4-triazin-6-one derivates
|
MX2007001713A
(es)
*
|
2004-08-11 |
2007-07-13 |
Donald L Barbeau |
Compuestos farmaceuticos no cardiotoxicos.
|
KR100915481B1
(ko)
|
2004-11-09 |
2009-09-03 |
에프. 호프만-라 로슈 아게 |
아미노퀴나졸린 화합물
|
US7498409B2
(en)
|
2005-03-24 |
2009-03-03 |
Schering Corporation |
Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists
|
CN101203519A
(zh)
|
2005-05-04 |
2008-06-18 |
辉瑞有限公司 |
用于治疗癌症和病毒感染如丙型肝炎的用作Toll样受体调节剂的2-酰氨基-6-氨基-8-氧代嘌呤衍生物
|
TW200716631A
(en)
|
2005-05-12 |
2007-05-01 |
Tibotec Pharm Ltd |
Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof
|
US7994360B2
(en)
|
2005-05-16 |
2011-08-09 |
Xtl Biopharmaceuticals Ltd. |
Benzofuran compounds
|
TWI404537B
(zh)
|
2005-08-19 |
2013-08-11 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之8-經取代苯并氮雜呯
|
EP1924564B1
(en)
|
2005-09-01 |
2016-11-09 |
F.Hoffmann-La Roche Ag |
Diaminopyrimidines as p2x3 and p2x2/3 modulators
|
US20090192153A1
(en)
|
2005-09-22 |
2009-07-30 |
Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan |
Novel adenine compound
|
WO2007056208A2
(en)
|
2005-11-02 |
2007-05-18 |
Cytovia, Inc. |
N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
EP1970373A1
(en)
|
2005-12-02 |
2008-09-17 |
Mitsubishi Tanabe Pharma Corporation |
Alicyclic heterocyclic compound
|
KR20080085232A
(ko)
|
2006-02-17 |
2008-09-23 |
화이자 리미티드 |
Tlr7 조절제로서 3-데아자퓨린 유도체
|
US9259426B2
(en)
|
2006-07-20 |
2016-02-16 |
Gilead Sciences, Inc. |
4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
|
WO2008009077A2
(en)
|
2006-07-20 |
2008-01-24 |
Gilead Sciences, Inc. |
4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
|
KR101507182B1
(ko)
|
2006-12-07 |
2015-03-30 |
제넨테크, 인크. |
포스포이노시타이드 3-키나제 억제제 화합물 및 그의 사용 방법
|
CA2672250C
(en)
|
2006-12-20 |
2013-04-30 |
Ian Stansfield |
Antiviral indoles
|
CN101790380B
(zh)
|
2007-02-07 |
2013-07-10 |
加利福尼亚大学董事会 |
合成tlr激动剂的缀合物及其应用
|
JP2008222557A
(ja)
|
2007-03-08 |
2008-09-25 |
Kotobuki Seiyaku Kk |
ピロロ[3,2−d]ピリミジン誘導体及びこれを有効成分とする医薬組成物
|
ES2457316T3
(es)
|
2007-03-19 |
2014-04-25 |
Astrazeneca Ab |
Compuestos 8-oxo-adenina 9 sustituidos como moduladores del receptor similares a toll (TLR7)
|
PE20081887A1
(es)
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Nuevo compuesto de adenina
|
WO2008114819A1
(ja)
|
2007-03-20 |
2008-09-25 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規アデニン化合物
|
WO2008147697A1
(en)
|
2007-05-22 |
2008-12-04 |
Boehringer Ingelheim International Gmbh |
Benzimidazolone chymase inhibitors
|
CA2691444C
(en)
|
2007-06-29 |
2016-06-14 |
Gilead Sciences, Inc. |
Purine derivatives and their use as modulators of toll-like receptor 7
|
JP2010535773A
(ja)
|
2007-08-10 |
2010-11-25 |
グラクソスミスクライン エルエルシー |
ウイルス感染を治療するための窒素含有二環式化学物質
|
JP2010538004A
(ja)
|
2007-08-28 |
2010-12-09 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
キナーゼ阻害剤としての2−ビフェニルアミノ−4−アミノピリミジン誘導体
|
WO2009030998A1
(en)
|
2007-09-05 |
2009-03-12 |
Coley Pharmaceutical Group, Inc. |
Pyrimidine compounds as toll-like receptor (tlr) agonists
|
PE20091236A1
(es)
|
2007-11-22 |
2009-09-16 |
Astrazeneca Ab |
Derivados de pirimidina como immunomoduladores de tlr7
|
EP2238142B1
(en)
|
2007-12-24 |
2012-07-04 |
Janssen R&D Ireland |
Macrocyclic indoles as hepatitis c virus inhibitors
|
WO2009099650A2
(en)
|
2008-02-07 |
2009-08-13 |
Carson Dennis A |
Treatment of bladder diseases with a tlr7 activator
|
JP2011518882A
(ja)
|
2008-04-28 |
2011-06-30 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Hcvns3プロテアーゼ阻害剤
|
US8946239B2
(en)
|
2008-07-10 |
2015-02-03 |
Duquesne University Of The Holy Spirit |
Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof
|
UY31982A
(es)
|
2008-07-16 |
2010-02-26 |
Boehringer Ingelheim Int |
Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas
|
ES2438496T3
(es)
|
2008-08-01 |
2014-01-17 |
Ventirx Pharmaceuticals, Inc. |
Formulaciones de agonistas de receptores de tipo toll y su uso
|
EA201101650A1
(ru)
|
2009-05-21 |
2012-07-30 |
Астразенека Аб |
Новые производные пиримидина и их применение в лечении злокачественных новообразований и последующих заболеваний
|
US8637525B2
(en)
|
2009-07-31 |
2014-01-28 |
Bristol-Myers Squibb Company |
Compounds for the reduction of beta-amyloid production
|
TWI468402B
(zh)
|
2009-07-31 |
2015-01-11 |
必治妥美雅史谷比公司 |
降低β-類澱粉生成之化合物
|
US20120232062A1
(en)
|
2009-10-20 |
2012-09-13 |
Eiger Biopharmaceuticals, Inc. |
Azaindazoles to treat flaviviridae virus infection
|
ES2644286T3
(es)
|
2009-10-22 |
2017-11-28 |
Gilead Sciences, Inc. |
Derivados de purina o deazapurina útiles para el tratamiento de (entre otros) infecciones víricas
|
KR101094446B1
(ko)
|
2009-11-19 |
2011-12-15 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 가지는 2,4,7-치환된 티에노[3,2-d]피리미딘 화합물
|
JP2013032290A
(ja)
|
2009-11-20 |
2013-02-14 |
Dainippon Sumitomo Pharma Co Ltd |
新規縮合ピリミジン誘導体
|
DE102010040233A1
(de)
|
2010-09-03 |
2012-03-08 |
Bayer Schering Pharma Aktiengesellschaft |
Bicyclische Aza-Heterocyclen und ihre Verwendung
|
US20120082658A1
(en)
|
2010-10-01 |
2012-04-05 |
Ventirx Pharmaceuticals, Inc. |
Methods for the Treatment of Allergic Diseases
|
WO2012066335A1
(en)
|
2010-11-19 |
2012-05-24 |
Astrazeneca Ab |
Phenol compounds als toll -like receptor 7 agonists
|
WO2012067269A1
(en)
|
2010-11-19 |
2012-05-24 |
Dainippon Sumitomo Pharma Co., Ltd. |
Aminoalkoxyphenyl compounds and their use in the treatment of disease
|
SI3330257T1
(sl)
*
|
2011-04-08 |
2020-07-31 |
Janssen Sciences Ireland Unlimited Company |
Derivati pirimidina za zdravljenje virusnih okužb
|
BR112013029537B1
(pt)
|
2011-05-18 |
2020-06-30 |
Janssen Sciences Ireland Uc |
derivados de quinazolina, seu uso no tratamento de infecções virais e outras doenças e composição farmacêutica que os compreende
|
ES2690082T3
(es)
|
2011-11-09 |
2018-11-19 |
Janssen Sciences Ireland Uc |
Derivados de purina para el tratamiento de infecciones virales
|
MX357296B
(es)
|
2012-02-08 |
2018-07-03 |
Janssen Sciences Ireland Uc |
Derivados piperidinopirimidinicos para el tratamiento de infecciones viricas.
|
NZ700928A
(en)
|
2012-04-24 |
2017-06-30 |
Vertex Pharma |
Dna-pk inhibitors
|
MX360718B
(es)
|
2012-07-13 |
2018-11-13 |
Janssen Sciences Ireland Uc |
Purinas macrocíclicas para el tratamiento de infecciones víricas.
|
ES2707885T3
(es)
|
2012-08-10 |
2019-04-05 |
Janssen Sciences Ireland Unlimited Co |
Alquilpirimidinderivados para el tratamiento de infecciones víricas y otras enfermedades
|
EP2712866A1
(en)
*
|
2012-10-01 |
2014-04-02 |
Centre National de la Recherche Scientifique (CNRS) |
1,2,4-triazine derivatives for the treatment of viral infections
|
ES2701098T7
(es)
*
|
2012-10-05 |
2021-02-03 |
Janssen Sciences Ireland Unlimited Co |
Derivados de acilaminopirimidina para el tratamiento de infecciones víricas y otras enfermedades
|
US9499549B2
(en)
|
2012-10-10 |
2016-11-22 |
Janssen Sciences Ireland Uc |
Pyrrolo[3,2-]pyrimidine derivatives for the treatment of viral infections and other diseases
|
JP6297055B2
(ja)
|
2012-11-16 |
2018-03-20 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
ウイルス感染症の治療のための複素環置換2−アミノ−キナゾリン誘導体
|
KR102300861B1
(ko)
*
|
2013-02-21 |
2021-09-10 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
바이러스 감염의 치료를 위한 2-아미노피리미딘 유도체
|
JP6336036B2
(ja)
|
2013-03-29 |
2018-06-06 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
ウイルス感染治療のための大環状デアザプリノン
|
SG11201509520QA
(en)
|
2013-05-24 |
2015-12-30 |
Janssen Sciences Ireland Uc |
Pyridone derivatives for the treatment of viral infections and further diseases
|
WO2014207082A1
(en)
|
2013-06-27 |
2014-12-31 |
Janssen R&D Ireland |
Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
|
MY179503A
(en)
|
2013-07-30 |
2020-11-09 |
Janssen Sciences Ireland Uc |
Thieno[3,2-d]pyrimidines derivatives for the treatment of viral infections
|
US9701661B2
(en)
|
2014-07-11 |
2017-07-11 |
Northwestern University |
2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase
|
JP7171444B2
(ja)
|
2016-07-01 |
2022-11-15 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
ウイルス感染治療用のジヒドロピラノピリミジン
|